跳至主要内容
临床试验/CTRI/2025/07/090230
CTRI/2025/07/090230招募中2/3 期

Randomized Controlled Clinical Trial Of Munditikadi Churna Along With Guduchi Kwath In Vatarakta

Dr Vishwjeet Vijaykumar Powar1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2025年7月15日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
74
试验地点
1
主要终点
Munditikadi churna along with guduchi kwath in the management

研究概览

简要总结

Vatarakta is a disease related with khavaigunya found in raktavaha strotas which include vitiated vata and rakta, so termed as vatarakta. Due to properties sukshmatva and saratva of vayu, dravatva and saratva of rakta they spread all over body. Vatarakta is a disease of Raktavaha strotas and is a Madhyam margagata vyadhi. (1) Prakupit Vayu along with Raktadushti travels in whole body & affects the joint starting with Parvasandhi especially Padangushta. Vatarakta is described as an independent disease as Vat-Shonita in CharakSamhita, Vagbhat and other samhitas The etiology and symptoms of gout is very much similar to those of vatarakta. Gout is a condition characterized by pathological reaction of joints or particular tissues. Purine is an important byproduct of incomplete protein metabolism, leading into the excess of production of uric acid through their metabolic pathways.The prevalence of Vatrakta is 2.5%.Gout is a chronic inflammatory condition caused by the deposition of MonosodiumUrate (MSU) crystal.It is caused by factors that elevate the concentration of SUA (Serum Uric Acid), leading to hyperuricemia. Continued elevated SUA can result in MSU (Monosodium Urate) crystal deposition in all over body, including joints, soft tissues, cartilage, and organs. The peak age of onset in males is between 40 and 60 years. Hyperurecemia can be defined as the serum uric acid level more than 7 mg/dL in males and 6 mg/dL in females.Classically, gout has been described as occurring in four stages: 1.asymptomatic hyperuricemia, 2.acute gouty arthritis,3. intecritical gout, and 4.advanced or chronic gout

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • 1.Patients would be selected Irrespective of their Gender.
  • 2.Patient presenting with lakshanas of vatrakta like Toda,shoth,daha and Sthabdhata.(10).

排除标准

  • Pregnancy and lactating woman.
  • Patient having major systemic illness.

结局指标

主要结局

Munditikadi churna along with guduchi kwath in the management

时间窗: 28 days

Vatarakta.

时间窗: 28 days

次要结局

  • Gud Haritaki along with guduchi kwath in the management(Vatarakta.)

研究者

发起方
Dr Vishwjeet Vijaykumar Powar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Vishwjeet Vijaykumar Powar

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center

研究点 (1)

Loading locations...

相似试验